Achievement and Safety of a Low Blood Pressure Goal in Chronic Renal Disease
- 1 February 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 29 (2) , 641-650
- https://doi.org/10.1161/01.hyp.29.2.641
Abstract
The Modification of Diet in Renal Disease Study showed a beneficial effect of a lower-than-usual blood pressure (BP) goal on the progression of renal disease in patients with proteinuria. The purpose of the present analyses was to examine the achieved BP, baseline characteristics that helped or hindered achievement of the BP goals, and safety of the BP interventions. Five hundred eighty-five patients with baseline glomerular filtration rate between 13 and 55 mL/min per 1.73 m 2 (0.22 to 0.92 mL/s per 1.73 m 2 ) were randomly assigned to either a usual or low BP goal (mean arterial pressure ≤107 or ≤92 mm Hg, respectively). Few patients had a history of cardiovascular disease. All antihypertensive agents were permitted, but angiotensin-converting enzyme inhibitors (with or without diuretics) followed by calcium channel blockers were preferred. The mean (±SD) of the mean arterial pressures during follow-up in the low and usual BP groups was 93.0±7.3 and 97.7±7.7 mm Hg, respectively. Follow-up BP was significantly higher in subgroups of patients with preexisting hypertension, baseline mean arterial pressure >92 mm Hg, a diagnosis of polycystic kidney disease or glomerular diseases, baseline urinary protein excretion >1 g/d, age ≥61 years, and black race. The frequency of medication changes and incidence of symptoms of low BP were greater in the low BP group, but there were no significant differences between BP groups in stop points, hospitalizations, or death. When data from both groups were combined, each 1–mm Hg increase in follow-up systolic BP was associated with a 1.35-times greater risk of hospitalization for cardiovascular or cerebrovascular disease. Lower BP than usually recommended for the prevention of cardiovascular disease is achievable by several medication regimens without serious adverse effects in patients with chronic renal disease without cardiovascular disease. For patients with urinary protein excretion >1 g/d, target BP should be a mean arterial pressure of ≤92 mm Hg, equivalent to 125/75 mm Hg.Keywords
This publication has 28 references indexed in Scilit:
- Long-term comparison between captopril and nifedipine in the progression of renal insufficiencyKidney International, 1992
- Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failureKidney International, 1992
- Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitorKidney International, 1992
- Long-term enalapril and verapamil in rats with reduced renal massKidney International, 1989
- Impact of Antihypertensive Therapy on Progressive Kidney DamageAmerican Journal of Hypertension, 1989
- Converting Enzyme Inhibition in Chronic Renal FailureAmerican Journal of Kidney Diseases, 1989
- Progression of renal insufficiency: Role of blood pressureKidney International, 1989
- Verapamil protects against progression of experimental chronic renal failureKidney International, 1987
- Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.Journal of Clinical Investigation, 1985
- EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHYThe Lancet, 1983